Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.25
-0.54 (-7.95%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $244.70 million as of October 31, 2024. Its market cap has decreased by -25.17% in one year.
Market Cap
244.70M
Enterprise Value
213.88M
1-Year Change
-25.17%
Ranking
Category
Stock Price
$6.25
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $616.87M to $244.70M, a decrease of -60.33%. That is a compound annual growth rate of -20.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 265.80M | -45.58% |
| Dec 29, 2023 | 488.40M | 54.85% |
| Dec 30, 2022 | 315.40M | -73.30% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 299.10% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 246.85M |
| Enanta Pharmaceuticals | 245.36M |
| Nkarta | 244.13M |
| ESSA Pharma | 243.59M |
| Precigen | 243.35M |
| Poseida Therapeutics | 240.86M |
| Lyell Immunopharma | 239.62M |
| High Tide | 239.15M |